Jiangbin Wang

551 total citations
29 papers, 311 citations indexed

About

Jiangbin Wang is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Jiangbin Wang has authored 29 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Surgery and 12 papers in Hepatology. Recurrent topics in Jiangbin Wang's work include Liver Disease Diagnosis and Treatment (11 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Hepatitis B Virus Studies (8 papers). Jiangbin Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Hepatitis B Virus Studies (8 papers). Jiangbin Wang collaborates with scholars based in China, Japan and Switzerland. Jiangbin Wang's co-authors include Yonggui Zhang, Changyu Zhou, Wenqian Qi, Xu Wang, Jian Jiao, Xu Wang, Ping Zhao, Yan Xu, Qian Zhang and Xiaohua Hou and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jiangbin Wang

28 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangbin Wang China 10 132 116 97 71 54 29 311
Niraj James Shah United States 9 141 1.1× 124 1.1× 88 0.9× 57 0.8× 51 0.9× 59 325
Tajana Filipec Kanižaj Croatia 12 202 1.5× 175 1.5× 140 1.4× 52 0.7× 34 0.6× 45 381
Charles Onyekwere Nigeria 14 199 1.5× 276 2.4× 109 1.1× 96 1.4× 76 1.4× 46 498
Suk Pyo Shin South Korea 13 74 0.6× 205 1.8× 30 0.3× 97 1.4× 96 1.8× 30 395
Amr Shaaban Hanafy Egypt 12 161 1.2× 113 1.0× 132 1.4× 38 0.5× 19 0.4× 43 350
Chih‐Chien Yao Taiwan 9 161 1.2× 127 1.1× 104 1.1× 62 0.9× 30 0.6× 36 367
Mohammad Minakari Iran 12 255 1.9× 220 1.9× 139 1.4× 121 1.7× 108 2.0× 38 537
Yuji Shimada Japan 11 93 0.7× 189 1.6× 58 0.6× 138 1.9× 34 0.6× 59 357
İnci̇ Süleymanlar Türkiye 10 90 0.7× 124 1.1× 46 0.5× 25 0.4× 32 0.6× 22 286
Ryuzo Deguchi Japan 11 55 0.4× 236 2.0× 29 0.3× 76 1.1× 84 1.6× 30 314

Countries citing papers authored by Jiangbin Wang

Since Specialization
Citations

This map shows the geographic impact of Jiangbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangbin Wang more than expected).

Fields of papers citing papers by Jiangbin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangbin Wang. The network helps show where Jiangbin Wang may publish in the future.

Co-authorship network of co-authors of Jiangbin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangbin Wang. A scholar is included among the top collaborators of Jiangbin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangbin Wang. Jiangbin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Shi, Jingyi, Xu Wang, Wenqian Qi, et al.. (2024). Association between NTCP hepatic expression and inflammation/fibrosis as well as gender‐specific differences in chronic HBV‐infected patients. Journal of Medical Virology. 96(1). e29428–e29428. 1 indexed citations
4.
Wang, Xuejiao, Jiangbin Wang, & Helin Li. (2023). Enhanced anticancer activity of piperine: Structural optimization and chitosan-based microgels with boosted drug delivery. International Journal of Biological Macromolecules. 253(Pt 5). 127019–127019. 10 indexed citations
5.
Liu, Jia, Wenqian Qi, Song Wang, et al.. (2023). Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus. Lipids in Health and Disease. 22(1). 91–91. 4 indexed citations
6.
Pan, Peng, Shengbing Zhao, Shuling Wang, et al.. (2023). Comparison of the efficacy and safety of an oral sulfate solution and 3-L polyethylene glycol on bowel preparation before colonoscopy: a phase III multicenter randomized controlled trial. Gastrointestinal Endoscopy. 98(6). 977–986.e14. 3 indexed citations
7.
Wang, Xu, Wenqian Qi, Jingyi Shi, et al.. (2023). Two genetic variants in the SRD5A2 gene are found to be associated with sex differences in the disease characteristics of patients with chronic hepatitis B virus infection. Biology of Sex Differences. 14(1). 68–68. 3 indexed citations
8.
Hou, Xiaohua, Fandong Meng, Jiangbin Wang, et al.. (2022). Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients. Journal of Gastroenterology and Hepatology. 37(7). 1275–1283. 41 indexed citations
9.
10.
Fan, Yu, et al.. (2020). Atypical adult-onset Still’s disease with an initial and sole manifestation of liver injury: A case report and review of literature. World Journal of Clinical Cases. 9(1). 224–231. 1 indexed citations
11.
Zhang, Qian, Xu Wang, Yan Xu, et al.. (2020). Long-term clinical benefit of Peg-IFNα and NAs sequential anti-viral therapy on HBV related HCC. Neoplasma. 68(1). 200–207. 4 indexed citations
12.
Wang, Jiangbin, Changyu Zhou, Yonggui Zhang, et al.. (2019). The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study. BMJ Open. 9(8). e027702–e027702. 3 indexed citations
13.
Wang, Song, et al.. (2018). Non-alcoholic fatty liver disease and the risk of urolithiasis. Medicine. 97(35). e12092–e12092. 18 indexed citations
14.
15.
16.
Xie, Wen, Yang Cao, Min Xu, et al.. (2017). Prognostic Significance of Elevated Cholestatic Enzymes for Fibrosis and Hepatocellular Carcinoma in Hospital Discharged Chronic Viral Hepatitis Patients. Scientific Reports. 7(1). 10289–10289. 10 indexed citations
17.
Zhang, Qian, Wenqian Qi, Xu Wang, et al.. (2015). Epidemiology of Hepatitis B and Hepatitis C Infections and Benefits of Programs for Hepatitis Prevention in Northeastern China: A Cross-Sectional Study. Clinical Infectious Diseases. 62(3). 305–312. 59 indexed citations
18.
Zhang, Manhua, et al.. (2013). Inhibitory effect of Lactobacillus acidophilus on Helicobacter hepaticus in vitro. World Journal of Microbiology and Biotechnology. 29(3). 499–504. 7 indexed citations
19.
Wang, Song, et al.. (2012). Impact of Interleukin-28B Polymorphism on Response to Treatment in Chinese Hepatitis C Patients. 高等学校化学研究(英文版). 1 indexed citations
20.
Wang, Jiangbin, et al.. (2008). Helicobacter pylori infection in patients with chronic hepatitis C and its related factors. World Chinese Journal of Digestology. 16(5). 535–535. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niraj James Shah Breakdown of academic impact, for papers by Tajana Filipec Kanižaj Breakdown of academic impact, for papers by Charles Onyekwere Breakdown of academic impact, for papers by Suk Pyo Shin Breakdown of academic impact, for papers by Amr Shaaban Hanafy Breakdown of academic impact, for papers by Chih‐Chien Yao Breakdown of academic impact, for papers by Mohammad Minakari Breakdown of academic impact, for papers by Yuji Shimada Breakdown of academic impact, for papers by İnci̇ Süleymanlar Breakdown of academic impact, for papers by Ryuzo Deguchi
Rankless by CCL
2026